Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
0,6%0,68%16.82x1.94x3.66x9.83x10.82x 66,11 Md
-.--%-.--%34.85x6.99x11.81x22.36x26.28x 42,44 Md
3,31%3,39%-46.4x2.53x3.26x9.63x11.23x 41,28 Md
-.--%-.--%31.76x1.63x3.6x11.15x12.97x 30,78 Md
-.--%-.--%-9.48x5.55x13.79x-8.46x-8x 32,46 Md
-.--%-.--%16.78x3.36x3.2x9.7x9.61x 23,1 Md
-.--%0,06%56.99x5.76x6.38x44.22x40.9x 20,06 Md
-.--%-.--%26.81x3.75x5.49x14.75x20.37x 17,19 Md
-.--%-.--%-35.74x-6.2x16.56x-50.36x-52.34x 15,23 Md
-.--%-.--%-123.08x12849.58x12.56x-111.25x-122.24x 12,48 Md
0,15%0,16%60.56x24.69x36.76x51.99x53.62x 11,57 Md
-.--%-.--%16.69x - 3.56x13.05x15.64x 11,36 Md
-.--%-.--%48.6x - - - - 11,05 Md
2,82%3,26%11.92x1.04x1.81x7.3x9.78x 6,24 Md
1,46%1,62%15.48x1.42x2.83x7.33x8.88x 6,2 Md
0,36%0,42%28.88x - 7.77x20.62x24.62x 5,88 Md
-.--%-.--%-109.27x - - - - 5,35 Md
Moyenne 0,51% 0,56% 2,48x 992,47x 8,87x 3,46x 4,14x 21,1 Md
Moyenne pondérée par Capi. 0,58% 0,62% 6,80x 497,13x 7,83x 6,53x 7,48x
Biopharmacies